PF-Atlas › Clinical Trials › NCT02334553
Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 in Subjects With Mild Atopic Asthma
S1226 · Phase 2
Registry ID
NCT02334553
Phase
Phase 2
Status
Completed
Drug / intervention
S1226(8%)
Sponsor
SolAeroMed Inc.
Start
2015-02-06
Enrollment
12
Locations
1
About this trial
Evaluate the safety and tolerability of a single dose of S-1226 (8%) in subjects with mild atopic asthma.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02334553 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.